Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. 10-Q filed May 1, 2026

Fiscal Q3 2026 · Period ended Mar 31, 2026 · Filed · accepted 6:19 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jan 30, 2026: 5 added · 1 removed · 27 modified; 32 with only figures updated

  1. Modified · Management’s Discussion and Analysis of Financial Condition and Results of Operations

    Net revenue from masks and other for the three months ended DecemberMarch 31, 20252026 increased to $529.7524.8 million from $456.3454.4 million for the three months ended DecemberMarch 31, 20242025, an increase of $73.470.4 million or 1615%, including an increase of 1614% in the U.S., Canada and Latin America and an increase of 1720% in combined Europe, Asia and other markets (an 8a 10% increase on a constant currency basis). Excluding the impact of foreign currency movements, masks and other sales for the three months ended DecemberMarch 31, 20252026 increased by 1412%.

32 more changes in this Item, word by word, in Powerpack.

Powerpack